Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Alembic Pharmaceuticals Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (367)
ARTG (144)
Prescription medicine registration (10)

Date

2025 (83)
2024 (10)
2023 (245)
2022 (10)
2021 (84)
2020 (22)
2019 (2)
2018 (17)
2017 (17)
2016 (3)
2015 (11)
2013 (11)
2012 (6)

Search

Sponsor content

521 result(s) found, displaying 441 to 450

ARIPIPRAZOLE APPL aripiprazole 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 November 2021

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
ARITRIEVAL ARIPIPRAZOLE aripiprazole 15 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 November 2021

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
ARIPIPRAZOLE APPL aripiprazole 15 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

18 November 2021

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
ARITRIEVAL ARIPIPRAZOLE aripiprazole 5 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

18 November 2021

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
ARIPIPRAZOLE APL aripiprazole 15 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

18 November 2021

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
ARILEMBIC ARIPIPRAZOLE aripiprazole 30 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

18 November 2021

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
ALEMBIC LACOSAMIDE, LACONAT, LACORESS, LACOSAMIDE AGH, LACOSAMIDE AGHL, LACOSAMIDE APL, LACOSAMIDE APPL, VICOMAT, VIGREN, VIMOLAC (Alembic Pharmaceuticals Australia Pty Ltd)

4 May 2021

Prescription medicine registration

Active ingredients: lacosamide.
JADELEM deferasirox 90 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 April 2021

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
JADELEM deferasirox 360 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 April 2021

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
JADELEM deferasirox 180 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

19 April 2021

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd

Pages

First page
Previous page
…
Page 41
Page 42
Page 43
Page 44
Current page 45
Page 46
Page 47
Page 48
Page 49
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.